Evidence map›Paper›PMID 35273759›Full record

ArticleSleep science (Sao Paulo, Brazil)

When adherence to CPAP fails, how do we treat workers with obstructive sleep apnea?

Maria de Lourdes Rabelo Guimarães, Pedro Guimarães Azevedo, Sérgio Barros-Vieira, Maxime Elbaz, Damien Leger, Ana Paula Hermont

Open access · diamondAbstract read
In one paragraph

Article in Sleep science (Sao Paulo, Brazil). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Maria de Lourdes Rabelo GuimarãesUniversidade Federal de Minas Gerais, Faculty of Medicine, Belo Horizonte, Brazil, - Belo Horizonte - Minas Gerais - Brazil.
Pedro Guimarães AzevedoUniversidade Federal de Minas Gerais, Faculty of Medicine, Belo Horizonte, Brazil, - Belo Horizonte - Minas Gerais - Brazil.
Sérgio Barros-VieiraUNISONO- Centre de Diagnostique et Traitement des Troubles du Sommeil, - Vitória - Espírito Santo - Brazil.
Maxime ElbazUniversité Paris Descartes, Sorbonne Paris Cité, EA, Vigilance Fatigue Sommeil et Santé Publique - Paris - Paris - France.
Damien LegerHôtel-Dieu, centre du Sommeil et de la Vigilance, Consultation de pathologie professionnelle Sommeil Vigilance et Travail, - Paris - Paris - France.
Ana Paula HermontUniversidade Federal de Minas Gerais, Faculty of Dentistry, Belo Horizonte, Brazil, - Belo Horizonte - Minas Gerais - Brazil.
Universidade Federal de Minas Gerais · BRDélégation Paris 5 · FRHospital Estadual Centra · BRMinistère du travail, de l'emploi et de l'insertion · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: A cross-sectional study was designed to evaluate the effectiveness of a mandibular advancement device (MAD) with respect to respiratory and sleep parameters among miners with obstructive sleep apnea syndrome (OSAS) and primary snore. Methods: The target sample was composed by 102 Brazilian miners with a history of non-adherence to continuous positive airway pressure. All patients were treated with a MAD and underwent pre and post-treatment full-night polysomnography. Ethical approval and consents were obtained. Bivariate and logistic regression analyses were conducted. The level of statistical significance was set at 5%. Results: After the treatment with MAD, 71.8% of patients presented a decrease ≥ 50% in the basal apnea-hypopnea index (AHI), 51.2% presented an AHI < 5 events/h and 83.3% reached an AHI<10/h, whereas 22.5% did not show any changes and 7.5% of the sample presented an increase in the AHI (p<0.05). There was an increase in the mean SpO2 nadir (p<0.001) and in the baseline duration of the REM sleep stage (p<0.05). The MAD significantly decreased snore events (p<0.05). Multivariate analysis did not identify predictive factors related to therapy success (decrease ≥ 50% of AHI). However, basal AHI was a significant predictor related to the secondary endpoint (AHI<10/h) (OR= 1.06, IC 95%1.00-1.13, p=0.007). Conclusions: The MAD therapy showed significant improvements in AHI, minimum oxygen saturation, REM sleep and snoring.

Indexed as

Mandibular Advancement DeviceObstructive Sleep ApneaOccupational MedicineOral AppliancesPrevention Of Accidents

Identifiers

PMID35273759
PMCPMC8889982
OpenAlexW4212798265

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.